Abiopharma

🔍 Paulson Richard A. (Executive)

Company: Karyopharm Therapeutics Inc. (KPTI)

Report Date: 2026-02-05

Detailed Transactions and Holdings:

• Acquired 81,060 shares of Common Stock (Direct)
  Date: 2026-02-05 | Code: A | equity_swap_involved: false | shares_owned_after: 279,391.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as to 50% of the shares on January 31, 2027, with the remaining 50% vesting on January 31, 2028.